←
Rubedo Life Sciences19 posts
Rubedo Life Sciences avatar

Rubedo Life Sciences

@LifeRubedo

Treating age-related diseases to extend health-span

◷ Joined December 2020▧ 2 Photos and videos
Rubedo Life Sciences avatar
Rubedo Life Sciences@LifeRubedo·22 May 2025

We’re excited to announce a major milestone at Rubedo Life Sciences: our first patients have been dosed! With this, Rubedo officially enters the clinic as a clinical-stage longevity biotech. businesswire.com/news/home/2…

Rubedo Life Sciences avatar
Rubedo Life Sciences@LifeRubedo·22 May 2025

breakthrough discovery: featured on the cover, our new paper on Nature Neuroscience with Prof. Tawfik lab at Stanford University, showing first-in-class senescence sensory neurons to treat neuropathic pain businesswire.com/news/home/2…

Rubedo Life Sciences avatar
Rubedo Life Sciences@LifeRubedo·23 Apr 2024

We are excited to announced a strategic partnership with @Beiersdorf_AG to advance the skincare industry with a disruptive and innovative product, born from deep science of aging and cellular senescence biology businesswire.com/news/home/2…

Rubedo Life Sciences avatar
Rubedo Life Sciences@LifeRubedo·23 Apr 2024

We are stocked to announced that we closed our $40M+ Series A led by @khoslaventures and Ahren Innovation capital to advance the company to the clinic with our first program, entry point to broader therapeutic areas of chronic diseases of aging businesswire.com/news/home/2…

C&EN (Chemical & Engineering News) avatar
⟳ Rubedo Life Sciences retweeted
C&EN (Chemical & Engineering News)@cenmag·22 Apr 2024

.@LifeRubedo just brought in $40 million in a series A financing round co-led by @khoslaventures and Ahren Innovation Capital. The start-up will develop medicines for aging cells that drive skin and fibrotic diseases: cen.acs.org/business/start-u…

Longevity Technology avatar
⟳ Rubedo Life Sciences retweeted
Longevity Technology@LongevityTech·22 Apr 2024

Rubedo lands $40m to advance senescence-targeting therapeutics into clinical trials... Longevity biotech @LifeRubedo plans Phase 1 #senotherapeutics trial this year as it seeks to keep people ‘biologically young.’ #longevity #investment #senescence longevity.technology/news/ru…

Phaedon Institute avatar
⟳ Rubedo Life Sciences retweeted
Phaedon Institute@PhaedonInstitut·17 Oct 2023

"There are no competitors in senotherapeutics – we are all collaborators." Great article by @LongevityTech discussing the upcoming #SenoTherapeuticsSummit with our President @MarcoQuarta12!

‘There are no competitors in #senotherapeutics – we are all collaborators’ Ahead of next month’s key #SenoTherapeuticsSummit, we talk to Dr Marco Quarta @PhaedonInstitut longevity.technology/news/th…